7 Ohio Cancer Docs Face Charges Over Drug Imports

Law360, New York (August 13, 2013, 7:07 PM EDT) -- Federal prosecutors on Tuesday announced misdemeanor charges against seven Ohio oncologists, accusing them of illicitly importing prescription drugs from foreign countries.

The medicines have all been approved by the U.S. Food and Drug Administration, but bringing them in from abroad constitutes so-called misbranding, prosecutors said.

Authorities said the imported medications included three cancer drugs — Sanofi-Aventis SA’s Taxotere and Eloxatin, and Eli Lilly and Co.’s Gemzar — as well as Novartis AG’s bone drug Zometa and Hoffmann-La Roche Ltd.’s anti-nausea treatment Kytril.

In announcing the charges,...
To view the full article, register now.